Dr. Avinash Dinmohamed
Dr. Avinash Dinmohamed
Senior researcher @ Netherlands Comprehensive Cancer Organisation (IKNL)
Geverifieerd e-mailadres voor iknl.nl - Homepage
Geciteerd door
Geciteerd door
Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands
AG Dinmohamed, O Visser, RHA Verhoeven, MWJ Louwman, ...
The Lancet Oncology 21 (6), 750-751, 2020
Two Plasmodium 6‐Cys family‐related proteins have distinct and critical roles in liver‐stage development
T Annoura, BCL van Schaijk, IHJ Ploemen, M Sajid, J Lin, MW Vos, ...
The FASEB Journal 28 (5), 2158-2170, 2014
The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands
AG Dinmohamed, M Cellamare, O Visser, L de Munck, MAG Elferink, ...
Journal of hematology & oncology 13 (1), 1-4, 2020
Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989–2012
AG Dinmohamed, O Visser, Y van Norden, NMA Blijlevens, ...
Leukemia 30 (1), 24-31, 2016
Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010
AG Dinmohamed, O Visser, Y van Norden, PC Huijgens, P Sonneveld, ...
European Journal of Cancer 50 (5), 1004-1012, 2014
Improved survival in adult patients with acute lymphoblastic leukemia in the Netherlands: a population-based study on treatment, trial participation and survival
AG Dinmohamed, A Szabo, M Van der Mark, O Visser, P Sonneveld, ...
Leukemia 30 (2), 310-317, 2016
Improved survival in primary central nervous system lymphoma up to age 70 only: a population-based study on incidence, primary treatment and survival in the Netherlands, 1989–2015
M van der Meulen, AG Dinmohamed, O Visser, JK Doorduijn, ...
Leukemia 31 (8), 1822-1825, 2017
The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands
AG Dinmohamed, Y van Norden, O Visser, EFM Posthuma, PC Huijgens, ...
Leukemia research 39 (2), 177-182, 2015
Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry
AG Dinmohamed, Y van Norden, O Visser, EFM Posthuma, PC Huijgens, ...
Leukemia 29 (12), 2449-2451, 2015
Improved survival for children and young adolescents with acute myeloid leukemia: a Dutch study on incidence, survival and mortality
AMJ Reedijk, K Klein, JWW Coebergh, LC Kremer, AG Dinmohamed, ...
Leukemia 33 (6), 1349-1359, 2019
Population-based analyses among 184 patients diagnosed with large granular lymphocyte leukemia in the Netherlands between 2001 and 2013
AG Dinmohamed, M Brink, O Visser, M Jongen-Lavrencic
Leukemia 30 (6), 1449-1451, 2016
Added value of interferon-gamma release assays in screening for tuberculous infection in the Netherlands
CGM Erkens, AG Dinmohamed, M Kamphorst, S Toumanian, ...
The International Journal of Tuberculosis and Lung Disease 18 (4), 413-420, 2014
Relative survival reaches a plateau in hairy cell leukemia: a population-based analysis in The Netherlands
AG Dinmohamed, EFM Posthuma, O Visser, AP Kater, RAP Raymakers, ...
Blood, The Journal of the American Society of Hematology 131 (12), 1380-1383, 2018
Validation of the FIRST simplified frailty scale using the ECOG performance status instead of patient-reported activities
CAM Stege, B van der Holt, AG Dinmohamed, P Sonneveld, MD Levin, ...
Leukemia 34 (7), 1964-1966, 2020
Primary therapy and relative survival in classical Hodgkin lymphoma: A nationwide population-based study in the Netherlands, 1989–2017
J Driessen, O Visser, JM Zijlstra, PJ Lugtenburg, WJ Plattel, MJ Kersten, ...
Leukemia 35 (2), 494-505, 2021
Guideline-based indicators for adult patients with myelodysplastic syndromes
K Stojkov, T Silzle, G Stussi, D Schwappach, J Bernhard, D Bowen, ...
Blood advances 4 (16), 4029-4044, 2020
Survival continues to increase in chronic lymphocytic leukaemia: a population-based analysis among 20 468 patients diagnosed in the Netherlands between 1989 and 2016
L van der Straten, MD Levin, O Visser, H Posthuma, J Doorduijn, A Kater, ...
British Journal of Haematology, 2020
Incidence of acute promyelocytic leukemia across Europe: results of RARECAREnet—a population-based study
AG Dinmohamed, O Visser
Stem Cell Investigation 6, 2019
Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population‐based study during 1990–2015
AMJ Reedijk, EAM Zijtregtop, JWW Coebergh, FAG Meyer‐Wentrup, ...
British journal of haematology 189 (6), 1093-1106, 2020
Intensive treatment and trial participation in elderly acute myeloid leukemia patients: A population-based analysis in The Netherlands
B Kalin, EN Pijnappel, M van Gelder, O Visser, AA van de Loosdrecht, ...
Cancer Epidemiology 57, 90-96, 2018
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20